Normally insulin levels are not measured in type-2 diabetes. Why?

AI Thread Summary
Type-2 diabetes is characterized by elevated blood glucose levels due to insulin resistance, where insulin is present but not functioning effectively. Most treatments involve insulin-based medications, yet routine testing for insulin levels is uncommon. The primary focus remains on monitoring blood sugar levels, as they directly correlate with health risks and are easier to measure. While insulin testing could provide additional insights into the disease, its complexity and the influence of various factors on insulin levels make it less practical for regular monitoring. The complexity of type-2 diabetes pathophysiology means that treatment effects extend beyond insulin stimulation, reinforcing the emphasis on blood glucose control as the main metric for managing the condition.
mktsgm
Messages
151
Reaction score
22
TL;DR Summary
Type-2 diabetes is generally correlated to hyperglycemia. The patients are routinely measuring glucose levels in their blood, but not their insulin levels. Why?
Type-2 diabetes patients generally display higher levels of glucose circulating in their blood. While type-1 is considered a lack of insulin disease, in type-2 it is considered that insulin may be present, but it is not working properly. It is called Insulin-resistance.

Most of the drugs for type-2 diabetes are insulin based (except some like Metformin etc), ie., they are either induced-endogenous or prescribed-exogenous insulin.

These type-2 patients are routinely prescribed to check their blood glucose levels (both fasting and pp) usually a test on their insulin levels is not tested. Even if the drugs are insulin-based, insulin levels are not tested in them.

I wonder, why it is so?

Is the information on insulin levels redundant or wasteful? Will it not be helpful to get the insulin levels routinely, for further treatment/understanding of the disease?
 
Biology news on Phys.org
I suspect the main reasons are pragmatic, really, in diabetes it is the blood sugar levels that cause the adverse health effects and testing this is simple, accurate and quick. The trouble with insulin testing is that there are a range of things that can affect the levels, and that there are factors other than insulin that can affect the blood sugar. They can and do check insulin production, but usually this is to help clarify the diagnosis, the blood sugar is a better measure to monitor the condition.

Type 2 diabetes is actually a bit more complex in terms of its pathophysiology, and the drugs used in treatment often have effects beyond just stimulating insulin production. The aim of treatment is to control the blood sugar levels, so that's what's measured, regardless of the way in which it's achieved.
 
  • Like
  • Informative
Likes dlgoff, BillTre, pinball1970 and 1 other person
Deadly cattle screwworm parasite found in US patient. What to know. https://www.usatoday.com/story/news/health/2025/08/25/new-world-screwworm-human-case/85813010007/ Exclusive: U.S. confirms nation's first travel-associated human screwworm case connected to Central American outbreak https://www.reuters.com/business/environment/us-confirms-nations-first-travel-associated-human-screwworm-case-connected-2025-08-25/...
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
Back
Top